Citation Impact
Citing Papers
Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
2015 Standout
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout
Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis
2018
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer
2013
Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress
2011
Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
2020
Role of the oral microbiota in cancer evolution and progression
2020
Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases
2020 StandoutNobel
Cancer statistics, 2020
2020 Standout
Tumor‐Derived Exosomes in Immunosuppression and Immunotherapy
2020
Combined modality therapy with TRAIL or agonistic death receptor antibodies
2011
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia
2007
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death
2016
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Activated PKR inhibits pancreatic β-cell proliferation through sumoylation-dependent stabilization of P53
2015
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-resistant Squamous Cell Carcinoma Cells by Induction of Noxa
2006
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Glutaminolysis and Transferrin Regulate Ferroptosis
2015 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Using transcriptome sequencing to identify mechanisms of drug action and resistance
2012
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Dynamics and functions of lipid droplets
2018 Standout
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
2014
Proteomic Analyses of Human Regulatory T Cells Reveal Adaptations in Signaling Pathways that Protect Cellular Identity
2018
Common pitfalls in preclinical cancer target validation
2017 StandoutNobel
Can NF-κB be a target for novel and efficient anti-cancer agents?
2006
Oxidative Stress in Cancer
2020 Standout
Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells
2022
Ferroptosis: process and function
2016 Standout
Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity
2019
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
The Bcl-2 apoptotic switch in cancer development and therapy
2007 Standout
Development of small-molecule probes that selectively kill cells induced to express mutant RAS
2011
The PI3K Pathway in Human Disease
2017 Standout
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
2008
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
2017
Reassessment of Exosome Composition
2019 Standout
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim
2010
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Cell Death Signaling
2015
Synthetic lethality: General principles, utility and detection using genetic screens in human cells
2010
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Role of Mitochondria in Ferroptosis
2018 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The integrated stress response
2016 Standout
Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
2017
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
3d Transition Metals for C–H Activation
2018 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
Targeting Treg cells in cancer immunotherapy
2019 StandoutNobel
Proteasome Inhibitor PS-341 Induces Apoptosis in Cisplatin-resistant Squamous Cell Carcinoma Cells by Induction of Noxa
2006
Noxa Up-regulation and Mcl-1 Cleavage Are Associated to Apoptosis Induction by Bortezomib in Multiple Myeloma
2007
Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non–small cell lung cancer cell line NCI-H460
2007
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug-Resistant Lung Cancer Cells
2008
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
The Biology of YAP/TAZ: Hippo Signaling and Beyond
2014
Cyanation of indoles with benzyl cyanide as the cyanide anion surrogate
2013
Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy
2012
Works of Wei Guo being referenced
Oxidative stress in NSC-741909-induced apoptosis of cancer cells
2010
Accelerated Degradation of Caspase-8 Protein Correlates with TRAIL Resistance in a DLD1 Human Colon Cancer Cell Line
2005
Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters
2012
Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation
2015
Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation
2005
Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy
2007
Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition
2011
High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)
2009
Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors
2005
Variations in Oral Microbiota Composition Are Associated With a Risk of Throat Cancer
2019
Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells
2012
Exosomes: New players in cancer
2017
Lkb1 maintains Treg cell lineage identity
2017
Anticancer Activity of 5-Benzylidene-2-Phenylimino-1, 3-Thiazolidin-4-one (BPT) Analogs
2006
The PI3K/AKT Pathway and Renal Cell Carcinoma
2015
Double-Stranded RNA-Dependent Protein Kinase-Dependent Apoptosis Induction by a Novel Small Compound
2008
Analogues and Derivatives of Oncrasin-1, a Novel Inhibitor of the C-Terminal Domain of RNA Polymerase II and Their Antitumor Activities
2011
Activation of Sterile20-Like Kinase 1 in Proteasome Inhibitor Bortezomib–Induced Apoptosis in Oncogenic K-ras-Transformed Cells
2006
Identification of a Small Molecule with Synthetic Lethality for K-Ras and Protein Kinase C Iota
2008
Identification of a Novel Synthetic Thiazolidin Compound Capable of Inducing c-Jun NH2-Terminal Kinase–Dependent Apoptosis in Human Colon Cancer Cells
2005